A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

Severe acute respiratory syndrome (SARS) is a serious infectious disease caused by the SARS coronavirus. We assessed the potential of prime-boost vaccination protocols based on the nucleocapsid (NC) protein co-administered with a derivative of the mucosal adjuvant MALP-2 or expressed by modified Vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulze, Kai, Staib, Caroline, Schätzl, Hermann M., Ebensen, Thomas, Erfle, Volker, Guzman, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115531/
https://www.ncbi.nlm.nih.gov/pubmed/18805454
http://dx.doi.org/10.1016/j.vaccine.2008.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115531/
https://www.ncbi.nlm.nih.gov/pubmed/18805454
http://dx.doi.org/10.1016/j.vaccine.2008.09.006

Ejemplares similares